BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 35290664)

  • 1. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
    Pedersen SK; Musher BL; LaPointe LC; Tuck MK; Symonds EL; Loayza N; Young GP
    Cancer; 2022 May; 128(10):1921-1928. PubMed ID: 35290664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
    Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
    Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
    Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.
    Young GP; Symonds EL; Nielsen HJ; Ferm L; Christensen IJ; Dekker E; van der Vlugt M; Mallant-Hent RC; Boulter N; Yu B; Chan M; Tevz G; LaPointe LC; Pedersen SK
    Clin Epigenetics; 2021 Jan; 13(1):14. PubMed ID: 33478584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer.
    Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L
    Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of methylated branched chain amino acid transaminase 1/IKAROS family zinc finger 1 for colorectal cancer.
    Xu K; Yu AR; Pan SB; He J
    World J Gastroenterol; 2023 Sep; 29(36):5240-5253. PubMed ID: 37901447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer.
    Al Naji H; Winter JM; Pedersen SK; Roy A; Byrne SE; Young GP; Symonds EL
    Biomark Insights; 2024; 19():11772719241232870. PubMed ID: 38426070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study.
    Brenne SS; Madsen PH; Pedersen IS; Hveem K; Skorpen F; Krarup HB; Giskeødegård GF; Laugsand EA
    Br J Cancer; 2023 Sep; 129(5):861-868. PubMed ID: 37438612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer.
    Petit J; Carroll G; Williams H; Pockney P; Scott RJ
    Med Sci (Basel); 2023 Sep; 11(3):. PubMed ID: 37755164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
    Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
    Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer.
    Mitchell SM; Ho T; Brown GS; Baker RT; Thomas ML; McEvoy A; Xu ZZ; Ross JP; Lockett TJ; Young GP; LaPointe LC; Pedersen SK; Molloy PL
    Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27983717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor.
    Leerhoff S; Raem A; Kolbe EW; Schulz L; Borchers K; Köhler T; Winde G; Kirchner C
    Cancer Treat Res Commun; 2023; 36():100748. PubMed ID: 37541105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies.
    Zhu M; Taylor WR; Mahoney DW; Then SS; Berger CK; Burger KN; Gonser AM; Doering KA; Xie H; Foote PH; Kaiser MW; Allawi HT; Hubbard JM; Kisiel JB
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utilization of circulating tumor DNA to predict the risk and location of relapse after curative-intent local therapy in oligometastatic colorectal cancer.
    Radomski SN; Ali S; Lafaro KJ; Shubert C; Hidalgo M; Chung H; Christenson ES
    J Gastrointest Surg; 2024 Apr; 28(4):534-537. PubMed ID: 38583907
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel microfluidic chip-based digital PCR method for enhanced sensitivity in the early diagnosis of colorectal cancer via mSEPT9.
    Huang Q; Xun Z; Lin J; Xie R; Zhu C; Wang L; Shang H; Wu S; Ou Q; Liu C
    Clin Chim Acta; 2024 Feb; 554():117781. PubMed ID: 38224929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer: which is ready for prime time?
    Danese E; Montagnana M; Lippi G
    Ann Transl Med; 2019 Nov; 7(21):610. PubMed ID: 32047771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylated BCAT1/IKZF1 DNA: a breakthrough in colorectal cancer diagnosis?
    Bhattarai A; Shah S; Khadka P; Serhan HA; Sah R; Sah S
    Ann Med Surg (Lond); 2024 Jan; 86(1):11-12. PubMed ID: 38222695
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer.
    Nakano T; Takao S; Dairaku K; Uno N; Low SA; Hashimoto M; Tsuda Y; Hisamatsu Y; Toshima T; Yonemura Y; Masuda T; Eto K; Ikegami T; Fukunaga Y; Niida A; Nagayama S; Mimori K
    Cancer Sci; 2024 Mar; ():. PubMed ID: 38531808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices.
    Malla M; Loree JM; Kasi PM; Parikh AR
    J Clin Oncol; 2022 Aug; 40(24):2846-2857. PubMed ID: 35839443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.